Clinical trial
Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children
NCT00453856 · Albert Schweitzer Hospital, Netherlands, Other · Terminated
Key facts
| NCT number | NCT00453856 |
|---|---|
| Title | Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children |
| Official title | Efficacy of Sulfadoxine-Pyrimethamine in the Treatment of Symptomatic, Uncomplicated Plasmodium Falciparum Malaria Among 6-59 Month Old Children in Lambaréné |
| Lead sponsor | Albert Schweitzer Hospital, Netherlands, Other |
| Collaborators | Albert Schweitzer Hospital Bill and Melinda Gates Foundation |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Sulfadoxine Pyrimethamine |
| Enrollment | 139 |
| Start date | Mar 1, 2007 |
| First posted | Mar 29, 2007 |
| Last update posted | Aug 10, 2007 |
| Countries | Gabon |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: